Skip to content

Opening book details…

About this Medicine article

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study by Feher, O. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Feher, O.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2005
Field
Medicine (Health Sciences)

More by Feher, O.

Browse all works by Feher, O.